Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review by den Bakker CM et al.
RESEARCH ARTICLE
Prognostic factors for return to work and
work disability among colorectal cancer
survivors; A systematic review
Chantal M. den Bakker1,2*, Johannes R. Anema1, AnneClaire G. N. M. Zaman3, Henrika C.
W. de Vet4, Linda Sharp5, Eva Angenete6, Marco E. Allaix7, Rene H. J. Otten8, Judith A.
F. Huirne9, Hendrik J. Bonjer2, Angela G. E. M. de Boer3, Frederieke G. Schaafsma1
1 Department of Occupational and Public Health, VU University medical center, Amsterdam Public Health
research institute, Amsterdam, The Netherlands, 2 Department of Surgery, VU University medical center,
Amsterdam, The Netherlands, 3 Academic Medical Center, Amsterdam Public Health research institute,
Coronel Institute of Occupational Health, University of Amsterdam, Amsterdam, The Netherlands,
4 Department of Epidemiology and Biostatistics, Amsterdam Public Health research institute, VU University
medical center, Amsterdam, The Netherlands, 5 Institute of Health & Society, Newcastle University,
Newcastle, United Kingdom, 6 Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy,
Gothenburg University, Go¨teburg, Sweden, 7 Department of Surgical Sciences, University of Torino, Torino,
Italy, 8 Medical Library, Vrije Universiteit, Amsterdam, The Netherlands, 9 Department of Gynaecology, VU
University medical center, Amsterdam, The Netherlands
* c.denbakker@vumc.nl
Abstract
Background
Colorectal cancer is diagnosed progressively in employed patients due to screening pro-
grams and increasing retirement age. The objective of this study was to identify prognostic
factors for return to work and work disability in patients with colorectal cancer.
Methods
The research protocol was published at PROSPERO with registration number
CRD42017049757. A systematic review of cohort and case-control studies in colorectal
cancer patients above 18 years, who were employed when diagnosed, and who had a
surgical resection with curative intent were included. The primary outcome was return
to work or work disability. Potentially prognostic factors were included in the analysis if
they were measured in at least three studies. Risk of bias was assessed according to the
QUality In Prognosis Studies tool. A qualitative synthesis analysis was performed due to
heterogeneity between studies. Quality of evidence was evaluated according to Grading
of Recommendation Assessment, Development and Evaluation.
Results
Eight studies were included with a follow-up period of 26 up to 520 weeks. (Neo)adjuvant
therapy, higher age, and more comorbidities had a significant negative influence on return
to work. A previous period of unemployment, extensive surgical resection and postoperative
PLOS ONE | https://doi.org/10.1371/journal.pone.0200720 August 15, 2018 1 / 18
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPENACCESS
Citation: den Bakker CM, Anema JR, Zaman
AGNM, de Vet HCW, Sharp L, Angenete E, et al.
(2018) Prognostic factors for return to work and
work disability among colorectal cancer survivors;
A systematic review. PLoS ONE 13(8): e0200720.
https://doi.org/10.1371/journal.pone.0200720
Editor: Aamir Ahmad, University of South Alabama
Mitchell Cancer Institute, UNITED STATES
Received: November 2, 2017
Accepted: July 2, 2018
Published: August 15, 2018
Copyright: © 2018 den Bakker et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This study was carried out with funding
of ZonMw (project number 837002409) (JRA), an
organisation for health research and development
in the Netherlands.
Competing interests: CdB, AZ, HdV, LS, EA, MA,
HB, AdB and FS have no conflicts of interest. JH
received grants from Dutch government bodies
such as NWO, ZonMw to perform research outside
complications significantly increased the risk of work disability. The quality of evidence for
these prognostic factors was considered very low to moderate.
Conclusion
Health care professionals need to be aware of these prognostic factors to select patients eli-
gible for timely intensified rehabilitation in order to optimize the return to work process and
prevent work disability.
Introduction
Colorectal cancer is the third most common type of cancer globally in men and the second in
women [1]. As a result of improvements in cancer treatment and general healthcare the aver-
age 5-year relative survival worldwide of colon cancer is now 57% and of rectal cancer 56% [2].
The lifetime risk of developing colorectal cancer in many regions worldwide is around 5% [3].
Over the past two decades, the number of colorectal cancer screening modalities has increased
and many population-based programs have been implemented [4]. Currently, most developed
countries already have some form of screening in place. As a result of screening, colorectal
cancer will be discovered and treated at an earlier stage [5]. The number of colorectal cancer
survivors is expected to increase further due to an ageing population in developed countries,
rising survival rates and the availability of screening.
Short-term morbidity and mortality are most commonly used endpoints of colorectal can-
cer treatment [6–7]. In contrast, there is limited literature available on long term post-opera-
tive recovery and rehabilitation of colorectal cancer patients. Recovery or rehabilitation has
been defined as the total or full recovery of a sick or disabled person by therapeutic measures
and return to activities of daily living within the limitations of the person’s physical disability
[8]. The time to full recovery after major abdominal surgery is currently not determined, how-
ever there are clear signs that a prolonged recovery period may be associated with a compro-
mised quality of life and depression, as well as shorter survival and severe economic burden
for patients as well as for society [9–10].
A critical element for full recovery after surgery is return to normal activities of which
return to work is considered one of the most important endpoint. Being able to work is seen as
a significant milestone of full recovery by many cancer patients [11]. It gives them self-confi-
dence, social interactions, a feeling of recovery and financial security [11–12]. At the moment
more than 30% of colorectal cancer survivors are below 65 years and are therefore often still
active in the workforce [1,3,13]. With the increasing retirement age in many developed coun-
tries, it is expected that more people will be diagnosed with colorectal cancer while they are an
active part of the workforce [14]. This increasing number of colorectal cancer patients in the
overall working population will have a profound economic impact in terms of lost productivity
due to temporary work cessation, permanent departure from the workforce (temporary reduc-
tion of working hours or workforce departure due to work disability) and premature mortality
[5,15].
Information about factors which may positively or negatively influence return to work or
work disability enables health care professionals to provide better information about voca-
tional rehabilitation to patients and their families. Therefore, the aim of this systematic review
was to give an overview of potentially relevant prognostic factors for the primary outcome
return to work or work disability of colorectal cancer survivors.
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Methods
A systematic review was performed following the ‘Preferred Reporting Items for Systematic
reviews and Meta-Analyses’ (PRISMA) guidelines [16]. A research protocol for this review was
agreed upon by all co-authors before starting the literature searches. The research protocol was
published online at the PROSPERO International prospective register of systematic reviews
(http://www.crd.york.ac.uk/PROSPERO/) under registration number: CRD42017049757.
Eligibility criteria
Studies fulfilling the following inclusion criteria were included:
I. Study designs. Retrospective- and prospective cohort studies as well as studies with a
case control design were included. There was no limitation to the minimal length of the fol-
low-up period in the cohort studies.
II. Participants. Studies on patients diagnosed with colorectal cancer of 18 years and
older, who were working at time of diagnosis and who had a surgical resection with a curative
intent were considered eligible. Studies investigating multiple cancer diagnoses were only
included when separate results were reported for colorectal cancer patients.
III. Outcome measures. The primary outcome of this study was return to work or work
disability. Return to work was defined as having (fully or partially) returned to work in previ-
ous or equal work after a period of sick leave during or at a certain follow up measurement
(e.g. after 1 year). Work disability was defined as not being able to meet the demands of gainful
activity during or at a certain follow up measurement, due to functional limitations caused by
impairment. Work disability was considered as a temporary or irreversible form of not work-
ing e.g. outcome measures such as: disability pension, sickness absence, work cessation, work
disability or incapacity were included [17–18].
IV. Prognostic factors. Prognostic factors concerning 1. person-related (e.g. age, gender);
2. diagnosis- or treatment-related (e.g. (neo)adjuvant therapy, type of surgery); and 3. occupa-
tional-related factors (e.g. type of work (blue/white collar) and workload) were eligible. If arti-
cles reported on the same study cohort, initially the index article was included in this review; if
the other article reported on additional prognostic factors, these factors were also included.
Search methods for identification of studies
The search strategy was developed with assistance from an experienced clinical librarian (RO)
to ensure an optimal search. The following electronic databases were used: (I) The Cochrane
Library, (II) Ovid MEDLINE, (III) Ovid EMBASE, (IV) PsycINFO (EBSCO host) and (V)
Cumulative Index to Nursing and Allied Health Literature (CINAHL) (EBSCO host). Addi-
tionally, the database of prognostic studies maintained by the Cochrane Prognosis Methods
Group (PMG) was used. References of papers considered eligible were cross-checked to
identify any further articles. Search terms included controlled terms (MeSH in PubMed and
Emtree in Embase) as well as free text terms. Only free text terms were used in The Cochrane
Library. Search terms expressing ‘return to work’ were used in combination with search terms
comprising ‘colorectal cancer’. Studies until 16 May 2018 were included. Only articles in
English or Dutch were eligible. The full electronic search strategy for MEDLINE is shown in
S1 File. Duplicate articles were excluded.
Study selection
Studies were selected independently by two of the authors (CdB and FS). Initially, the titles
and abstracts were screened and full reports from potentially relevant studies were retrieved.
Prognostic factors for return to work and work disability among colorectal cancer survivors
PLOS ONE | https://doi.org/10.1371/journal.pone.0200720 August 15, 2018 3 / 18
The authors used EndNote to assess and document the full reports on inclusion or exclusion
according to the predefined selection criteria. Disagreements were resolved by discussion and
where agreement could not be reached, a third reviewer was consulted (AdB).
Data extraction
Data extraction was performed by CdB and checked by FS. Data on author, year of publication,
setting, study population, study design, follow-up duration, measuring methods, timing of
outcome assessment, and prognostic factors were extracted. The odds ratio, hazard ratio, risk
ratio, incidence rate ratio or regression coefficient was extracted as the estimate of the effect
size. Univariate effect sizes were used even if the multivariate effect sizes were also presented,
as we were interested in prediction and not to assess causality [19]. Disagreements were
resolved by discussion or by involving JA as arbiter. When there were uncertainties about the
reported data, authors of included studies were contacted. The authors of Van den Brink et al
2005, Gordon et al 2014 and Carlsen et al 2013 were all contacted, but only Van den Brink
et al. replied but they could not give more clarity about their data. As a result, for all studies
only the published data was used in this review.
Quality assessment of individual studies
For assessing the quality of individual studies the widely used QUality In Prognosis Studies
tool was applied [20–21]. Six domains are critical for assessing biases that potentially distort
the findings of prognosis research: (I) selection of study participants, (II) study attrition, (III)
prognostic factor measurement, (IV) outcome measurement, (V) study confounding and (VI)
statistical analysis and reporting. For each of these 6 domains, the responses ‘yes’, ‘partial’, ‘no’
or ‘unsure’ for three up to seven items within each domain are combined to assess the risk of
bias. An overall rating for each domain is assigned as ‘high’, ‘moderate’ or ‘low’ risk of bias.
The QUality In Prognosis Studies assessment for each study was independently completed by
CdB and AZ. Differences were resolved by discussion or by referral to FS. A study was consid-
ered to be of low risk of bias when the items were rated as low or moderate on all of the six
domains, with at least four rated as low (of which the outcome measurement domain must be
rated as low at least). A study was scored as high risk of bias if two or more of the domains
were scored as high. The remaining studies were scored as moderate [21–22].
Data analysis
It was decided to include a potential prognostic factor in the analysis when this factor was mea-
sured in at least three different studies. This threshold was chosen to increase the ability to
draw conclusions about the consistency and relevance of these factors [19,23]. After data
extraction and selection of prognostic factors the homogeneity between included studies per
prognostic factor was assessed. A meta-analysis of prognostic factors was considered inappro-
priate due to the high heterogeneity in the definition and/or operationalization of the prognos-
tic factors between the studies. To have more insight into the effects per factor on the outcome
measures, a forest plot (without the pooled effect) was used. For these plots, the reported effect
parameters and 95% confidence intervals in individual studies of prognostic factors were first
converted into effect sizes that measured the effect comparably to ensure comparison of each
prognostic factor. Regression coefficients were converted into effect sizes using the standard
deviation of the prognostic factor, and odds ratios were converted into risk ratios using the
non-exposed prevalence. For the analysis the number of studies evaluating a specific prognos-
tic factor and the consistency of the direction of the results of these studies was taken into
account. Although, the follow-up periods differed across included studies, the directions of the
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effect from the prognostic factors on our primary outcomes were comparable. As such, we did
not further stratify the analysis based on the follow-up period. A potentially prognostic factor
was considered consistent if >75% of the studies reporting on this factor showed the same
statistically significant direction of the association with the outcome. After initial review, an
exception to this criterion was applied in case of three studies. In that case, it was decided to
assume that two out of three studies (i.e. 67%) had to show statistically significant results in the
same direction. Prognostic factors with a significant association in <75% of the included stud-
ies were considered inconclusive [24–25].
Grading of Recommendation Assessment, Development and Evaluation
The Grading of Recommendation Assessment, Development and Evaluation on prognosis
research was used to rate the overall evidence per factor in order to evaluate the limitations of
all eligible studies [26]. The Grading of Recommendation Assessment, Development and Eval-
uation was assessed according to the standard framework. Evidence on prognostic studies was
evaluated by six factors that may decrease quality: (I) phase of investigation; (II) study limita-
tions; (III) inconsistency; (IV) indirectness; (V) imprecision; and (VI) publication bias. Factors
that may improve the quality of evidence were; (I) moderate or large effect size; and (II) expo-
sure-response gradient.
Results
The literature search resulted in a total number of 3 968 hits. After duplicate removal, 3 438
hits were screened on title and abstract. This resulted in 79 full-text articles that were assessed
for eligibility, of which eight studies described in nine articles met the inclusion criteria (Fig 1).
Study characteristics
The characteristics of the included studies are presented in Table 1 [27–35]. Two of the
included studies focussed only on return to work [28–30], four studies on work disability [32–
35], and two studies on both outcomes [27–31]. Variations in definitions and measurements
of work disability were evident. Three studies reported about disability pension, two about
work cessation and one about sickness absence. Of the eight included studies, most studies
(n = 6 studies) were prospective cohort studies [27–31,33–34]. The remaining studies were
case-control studies [32,35]. Studies were executed in six different countries; most of them in
Europe (n = 6 studies) [29–33,35], and two in Australia [27–28,34]. There was considerable
variation across studies regarding sample size and length of follow-up. The sample size ranged
from 50 up to 4343 patients. The follow-up period ranged from 26 up to 535 weeks; five of the
included studies had a follow-up longer than 1 year [29,31–33,35]. For return to work, the arti-
cles of Gordon et al 2014 and Lynch et al 2015 dealt with one study cohort and were therefore
combined to one study for this outcome measure [27–28]. The study by Van den Brink et al
2005 reported only regression coefficients without SD’s, making it impossible to calculate
effect sizes. However, with these regression coefficients a positive or negative direction of the
effect on return to work could be determined. The effects of Van den Brink et al 2005 are
therefore reported in the plots with an asterisk () [29].
Risk of bias within studies
The overall ‘Risk of Bias’ of each included study is presented in Fig 2. Overall agreement on
methodological quality scores between the reviewers was 81.5%. Cases where reviewers dis-
agreed mainly concerned the rating of attrition of patients and the confounding factors.
Prognostic factors for return to work and work disability among colorectal cancer survivors
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Consultation of a third reviewer was necessary to resolve disagreement for 18.5% of all scores.
One study was considered to have low risk of bias, all other seven studies have moderate risk
of bias mainly due to the variety in measuring and categorization of the prognostic factors.
Included prognostic factors
In Table 2, all reported prognostic factors are presented. The amount and type of potentially
prognostic factors investigated varied per study. The operationalization of these factors also
differed between studies. Four studies assessed a total of 32 potential prognostic factors for
return to work [27–31] and six studies assessed a total of 33 potential prognostic factors for
Fig 1. PRISMA diagram showing selection of studies for systematic review.
https://doi.org/10.1371/journal.pone.0200720.g001
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work disability [27,31–35]. In total 10 factors on person-related factors, 14 factors on diagno-
sis- or treatment-related factors and 8 factors on occupational-related factors in the return to
work studies were measured. Furthermore, in total 9 factors on person-related factors, 14 fac-
tors on diagnosis- or treatment-related factors and 10 factors on occupational-related factors
in the work disability studies were measured. The prognostic factors that were analysed in at
least three studies are shown in bold in Table 2.
Prognostic factors for return to work
In Fig 3 the prognostic factors for return to work are presented. In total five factors were
included in this analysis, two person-related-, two diagnosis- or treatment-related-, and one
occupational-related factor based on the criterion that a factor should be measured in at least
3 studies. The effect sizes of non-included factors on return to work are presented in S1 Table.
Of the remaining 27 potential prognostic factors, four factors were investigated in two studies
and 23 only in one study.
Person-related factors. Three studies reported on age [28–29,33], and three on education
[27,29,31]. An higher age was consistently negatively associated with return to work. For the
factor education inconclusive evidence was found for their association with return to work,
because of an opposite effect in these studies (Fig 3).
Diagnosis- or treatment-related factors. Three studies reported on (neo)adjuvant ther-
apy (supplementary to surgery) [28–30], and three on comorbidity [28–29,31]. Receiving (neo)
Table 1. Characteristics of included articles on return to work or work disability in colorectal cancer survivors.
Characteristics of included articles
Author Year Country Design n Age in years
mean (sd)
Gender
male (%)
Follow-up
(week)
Measurement Outcome Operationalization of
the outcome
Articles discussing Return to Work
Bains et al. 2011 United
Kingdom
Prospective
cohort study
50 52.5 (5.4) 28 (56) 26 Questionnaire Employment Working vs not
working
van den Brink
et al.
2005 The
Netherlands
Nested cohort
study
292 52 (7) 144 (49.3) 104 Database
questionnaire
Paid labor
resumption
Working vs not
working
Articles discussing Work Disability
Chen et al. 2015 Sweden Matched cohort
study
2
815
55 (NA) 1 686
(59.9)
520 Database
National register
Disability
pension
DP cases per person-
years at risk
Chen et al. 2016 Sweden Prospective
cohort study
3
438
56 (20–61)
median
(range)
1 985
(57.7)
260 Database
National register
Sick leave Net days of SL and DP
Disability
pension
Gordon et al. 2008 Australia Population-based
longitudinal study
975 60.2 (10.4) 621 (63.7) 52 Database
questionnaire
Work
cessation
Yes or no
Hauglann
et al.
2014 Norway Controlled cohort
study
648 51 (NA) 381 (58.8) 728 Database
National register
Disability
pension
Yes or no
Articles discussing both Return to Work and Work Disability
Carlsen et al. 2013 Denmark Register-based
cohort study
4
343
53.8 (NA) 2430
(56.0)
535 Database
National register
Sickness
absence
Yes or no
Return to
work
Working vs not
working
Gordon et al.
/ Lynch et al
2014 /
2016
Australia Prospective
population-based
study
239 56 (5.5) 160 (67) 52 Database &
questionnaire
Work
cessation
Not working at 12
months
Work
resumption
Net days of RTW
SL = Sick leave; DP = Disability pension; RTW = Return to work
https://doi.org/10.1371/journal.pone.0200720.t001
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adjuvant therapy and having more comorbidities were consistently negatively associated with
return to work (Fig 3).
Occupational-related factors. Three studies reported on type of occupation (manual vs
non-manual work was investigated) [27,30–31]. For this factor inconclusive evidence was
found on return to work as in none of the studies a significant effect on return to work was
found (Fig 3).
Prognostic factors for work disability
In Fig 4 the prognostic factors for work disability are presented. In total, nine factors were
included in this analysis, three person-related-, four diagnosis- or treatment-related- and
two occupational-related factors based on the criterion that a factor should be measured in at
least three studies. The effect sizes of non-included factors on return to work are presented in
Fig 2. Risk of bias according to the QUIPS tool. Red circle = High risk of bias, orange circle = moderate risk of bias,
green circle = low risk of bias.
https://doi.org/10.1371/journal.pone.0200720.g002
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S2 Table. Of the remaining 24 potential prognostic factors, five factors were investigated in
two studies and 19 only in one study.
Person-related factors. Four studies reported on age [27,33–35], three on gender [27,33,35],
and five on education [27,31,33–35]. For all these factors inconclusive evidence was found for
their association with work disability. In two out of four studies a higher age had a significant
Table 2. Prognostic factors measured in included articles.
Prognostic factors
Return to Work Work Disability
Person-related Person-related
Age Age
Education Gender
Gender Education
Vegetable/fruit consumption BMI
Alcohol consumption Residence area
Smoking status Marital status
Sitting time Private health insurance
Marital status Children in household
BMI People in household
Perceived prosperity
Diagnosis- or treatment-related Diagnosis- or treatment-related
Comorbidity Type of surgery
(Neo)adjuvant therapy Postoperative complications
Type of surgery (Neo)adjuvant therapy
Type of cancer Stage
Stage Type of cancer
ASA classification ASA classification
Curative operation Curative operation
Postoperative complications Reoperation
Stoma fitted Hospital volume
Hospital length of stay Energy
Phyiscal Symptom Distress Physical component of SF-12
Limitations in daily activities Surgical complications
Energy Non-surgical complications
Physical activity Comorbidities
Occupational-related Occupational-related
Occupation Occupation
Income Previous unemployment
Previous periods of work Income
Previous period of sick absence Previous periods of work
Previous unemployment Previous period of sick absence
Job self-efficacy Employer size
Work ability Time at employer
Employer size Work contract
Work hours prior to cancer
Total household income
Bolded and underlined prognostic factors are measured in at least 3 studies and thus included in the analysis.
https://doi.org/10.1371/journal.pone.0200720.t002
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Fig 3. Plots per prognostic factor, measured in at least 3 studies, for return to work (RTW). 1 Significant different.  direction of regression
coefficient. Gordon is parent study, Lynch other study (both using the same study cohort).
https://doi.org/10.1371/journal.pone.0200720.g003
Fig 4. Plots per prognostic factor, measured in at least 3 studies, for work disability. 1 Significant different. $ Converted from OR into RR.
https://doi.org/10.1371/journal.pone.0200720.g004
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effect on the risk for work disability. For gender in only one out of the three studies a significant
risk for work disability was found for women compared to men. And for the factor education,
three studies reported a significant risk for work disability due to lower type of education, how-
ever other studies reported no or an opposite effect (Fig 4).
Diagnosis- or treatment-related factors. Three studies reported on (neo)adjuvant ther-
apy (supplementary to surgery) [32–34], three studies on type of surgery [31–33], five studies
on stage of disease [31–35], and three studies on postoperative complications [31–33]. Receiving
more extensive surgery and experiencing more postoperative complications after surgery
resulted in a higher risk of work disability. For the factors stage of disease and (neo)adjuvant
therapy (supplementary to surgery) inconclusive evidence was found on work disability. For
disease stage in only three out of five studies a significant increase in the risk for work disability
was reported. For (neo)adjuvant therapy (supplementary to surgery) in only one out of three
studies a significant increase in the risk for work disability was reported (Fig 4).
Occupational-related factors. Three studies reported on previous unemployment
[31,33,35], and three on occupation [27,31,34]. Having a previous period of unemployment
(before the colorectal cancer diagnosis) resulted in a higher risk of work disability. For the
factor occupation (manual vs non-manual work was investigated) inconclusive evidence was
found on the risk for work disability, because only one out of three studies reported this effect
(Fig 4).
Grading of Recommendation Assessment, Development and Evaluation
The Grading of Recommendation Assessment, Development and Evaluation classification
per prognostic factor for return to work and work disability is presented in Table 3. Moderate
evidence was found for the factor postoperative complications according to this classification
Table 3. Grading of Recommendation Assessment, Development and Evaluation classification per significant prognostic factor for return to work and work
disability.
GRADE factors Overall
qualityPhase of
investigation
Study
limitations
Inconsis-
tency
Indirectness Imprecision Publication
bias
Moderate / large
effect size
Dose
effect
Return to work
Age
p
✘ ✘ ✘
p p
NA ✘ +
(Neo)adjuvant
therapy
p
✘
p p
✘
p
NA ✘ + +
Comorbidites
p
✘ ✘ ✘
p p
NA ✘ +
Work disability
Type of surgery
p
✘
p
✘
p p
NA ✘ + +
Postoperative
complications
p
✘
p p p p
NA ✘ + + +
Previous
unemployment
✘ ✘
p p p p
NA ✘ + +
Grading of Recommendation Assessment, Development and Evaluation factors:
p
= no serious limitations
✘ = serious limitiations
NA = not applicable or unknown
For overall quality of evidence:
+ = very low
++ = low
+++ = moderate.
https://doi.org/10.1371/journal.pone.0200720.t003
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system, only downgrading for study limitations was necessary given the moderate risk of bias
of included studies.
Low evidence was found for (neo)adjuvant therapy, type of surgery and previous unemploy-
ment. All these factors were downgraded for study limitations due to the moderate risk of bias
of included studies. The factor (neo)adjuvant therapy was downgraded for imprecision given
the included underpowered study of Bains et al which did not provide a rationale for the chosen
sample size [30]. The factor type of surgery was downgraded for indirectness due to the variation
in operationalization of the prognostic factor itself. The factor previous unemployment was
downgraded for phase of investigation due to included studies that were not primarily designed
to examine prognostic factors for work disability, but this was performed as sub analysis.
Very low evidence was found for age and comorbidities. These factors were downgraded for
study limitations due to moderate risk of bias of included studies, for inconsistency because
only two out of the three studies found a significant effect, and for indirectness due to the vari-
ation in operationalization of the prognostic factor itself.
Discussion
A form of (neo)adjuvant therapy, higher age and more comorbidities had a negative influence on
return to work. For the other two included factors on return to work inconclusive results were
found. A previous period of unemployment, extensive surgery and postoperative complications
were considered to increase the risk for work disability. For the other six included factors on
work disability inconclusive results were found.
For this review, only a limited number of studies on prognostic factors on colorectal cancer
survivors’ return to work and/or work disability were available. This can probably be explained
by the high average age at diagnosis in the past, as such patients were typically no longer part
of the work force. Another, notable finding was the various ways of measuring the outcome
measures, mostly depending on the nation in which the study was executed. The definition
of return to work and work disability is not consistent across national social security systems
or other stakeholders responsible for the financial benefits for sick workers, explaining the
reported variation of these outcome measures [36–38]. Partly as a consequence, there is also
no consensus in the research community how these outcomes and prognostic factors should
be measured or operationalized.
Prognostic factors can be divided into non-modifiable and potentially modifiable factors.
The relevant prognostic factors for return to work and work disability measured in this review
were non-modifiable (diagnosis / treatment) or less easy to modify (therapy-related). However,
the assessment of these non- or difficult modifiable factors remains relevant information for
health care professionals advising about return to work / work disability for colorectal cancer
survivors [39]. Early identification of risk factors will improve the guidance for return to work
[39]. A number of systematic reviews regarding multiple cancer diagnoses have also investi-
gated potential prognostic factors for return to work [40–49]. Diagnosis- or treatment-related
factors ((neo)adjuvant therapy, the type of surgery or postoperative complications) were also
relevant prognostic factors in these systematic reviews [40,46,48]. However, these reviews also
reported on more relevant occupational-related factors, such as blue vs white collar professions
and the amount of working hours compared to the results of this review [40–49]. This may
be explained by the limited number of included studies in our review. Identification of work
related factors is however valuable when interpreting the outcome of return to work or work
disability after colorectal cancer treatment. Besides, these factors are usually more modifiable
and as such can be used to facilitate return to work (e.g. adjusting manual into non-manual
work, optimizing relationships with colleagues and employers) [5].
Prognostic factors for return to work and work disability among colorectal cancer survivors
PLOS ONE | https://doi.org/10.1371/journal.pone.0200720 August 15, 2018 12 / 18
The main strength of this review is that this is the first systematic review regarding prognos-
tic factors for return to work and work disability among colorectal cancer survivors. This
review has revealed that much more longitudinal observational studies are necessary focusing
on particular relevant factors for this target group that will increase in the number of people
that wishes to return to work after treatment over the next few years. Another strength of this
review is the methodological quality, ensured by following the PRISMA guidelines for system-
atic reviews [16]. An extensive literature search was conducted based on a comprehensive
search strategy developed by an clinical librarian with expertise in the field. By including both
cohort studies as well as case control studies, we are confident that this review presents a full
overview of existing studies on this topic.
Despite the extensive search, a potential limitation may be the exclusion of non-English
studies and grey literature. Furthermore, all studies investigating multiple cancer diagnoses
were excluded when no separate results were reported for colorectal cancer survivors, this may
have caused some bias in our results. In addition, the majority of the studies did not make a
distinction between the diagnoses colon- or rectal cancer with corresponding different treat-
ment strategies. As a result we could not separate these diagnoses in the analysis. Another limi-
tation can be that the differences in categorizations of prognostic factors may be of influence
on the total conclusion of a prognostic factor. It was decided to draw conclusions despite these
differences. In addition, our threshold of only reporting on a factor that was included in at
least three studies may have been too strict. Hereby, it is possible that other important factors
may not be included in the analysis. In order to give full disclosure for all prognostic factors,
the categorization is presented in the plots in Figs 3 and 4 and the number of studies investigat-
ing a prognostic factor are presented in S1 and S2 Tables. Lastly, the QUIPS tool is a non-vali-
dated instrument which could give room for personal interpretation. This was addressed by
discussing the use of this tool in advance with an expert (HdV) in the prognostic research
field. In addition, the QUIPS tool is recommended by the Cochrane Methods Prognosis group
and designed for prognosis studies addressing all common sources of bias [50]. Based on this,
we considered the tool as suitable for evaluating risk of bias. The allocated quality marks that
were used to discriminate study quality as well as the chosen cut-off points are considered
arbitrary.
The primary postoperative focus of most health care professionals (e.g. surgeons and / or
oncologists) is naturally on the patients’ recovery, possible complications or side effects
[39,51]. As a result, in practice there is only limited focus on full long term recovery including
return to normal activities and return to work [6–7]. Previous studies report that patients
often receive conflicting advice about their recovery period after colorectal cancer surgery by
health care professionals, and that the degree of guidance and monitoring towards full recov-
ery such as return to work is sometimes limited [44,52]. Furthermore, in general, limited
work-related advice is provided by health care professionals [53]. This may be a result of insuf-
ficient time at the outpatient clinic or the lack of knowledge of health care professionals about
vocational rehabilitation in general [51]. Therefore, often colorectal cancer survivors should
decide about the best time to return to work themselves which can be difficult to judge and
as such can unnecessarily prolong the time for return to work [12,51]. Previous research
on benign gynecological procedures showed that patients achieve earlier return to work if
health care professionals provide tailored and personalized advice by eHealth and ICT on the
resumption of normal activities including return to work [53–55]. The same goes for a more
sustainable work ability which can be achieved when healthcare professionals are more aware
of the work-related goals of their patients [39]. Taken together, this evidence suggest that it
may be beneficial for colorectal cancer patients and survivors if attention is paid to work
related goals during treatment. More collaboration between health care professionals and
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occupational physicians is receiving increased attention by researchers [56–57], as underlined
in a recently performed multicenter randomized controlled trial in which tailored work-
related support is provided by an oncological nurse, occupational physician or in a multidisci-
plinary team [58]. Prognostic factors found in this systematic review can already assist in guid-
ing colorectal cancer patients by health care professionals (especially surgeons and medical
oncologists). Four out of six identified prognostic factors are based on the diagnosis or treat-
ment, thus surgeons and oncologists can prepare colorectal cancer patients about the influence
of their treatment on the process of return to work.
A recommendation for the absence of uniform definitions for return to work and work dis-
ability is to develop an agreed standard “core” set of outcomes that should be used in all trials
to facilitate cross-study comparisons, meta-analysis, and minimize outcome reporting bias
[59]. Although, there are already three articles available regarding colorectal cancer surgery
and core outcome sets [60–62], up to now there is no “core” set. In one of these articles a sys-
tematic review regarding patient reported outcomes demonstrated a significant heterogeneity
of patient reported outcomes measurement that may hinder comparisons between studies,
limit meta-analysis and allow outcome reporting bias. Unfortunately, no core outcome set for
full recovery, return to work and return to normal activities is obtained in this set regarding
patient reported outcomes [60]. Based on the high heterogeneity of ways that the outcome
measures were reported in the studies included in this review, the suggestion to future
researchers or developers of core outcome sets is to widen the eligible factors for the core out-
come set and to consider to include patient reported outcomes regarding full recovery, return
to work and return to normal activities.
In conclusion, a form of (neo)adjuvant treatment, higher age and more comorbidities predis-
pose for later or no return to work for patients recovering from colorectal cancer. A previous
period of unemployment, extensive surgery and postoperative complications increase the risk
for work disability. Health care professionals need to be aware of these factors to select those
patients for intensified rehabilitation to improve return to work and prevent work disability. It
is highly recommend to create more uniformity in design and methodology in future studies
and there is a need for more high-quality longitudinal studies on this topic.
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